Research graph
References from Oxygen-augmented erythrocyte-liposome hybrids to overcome paclitaxel resistance in triple-negative breast cancer metastasis via enhanced ferroptosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Targeting pivotal hallmarks of cancer for enhanced therapeutic strategies in triple-negative breast cancer Treatment-In vitro, in vivo and clinical trials literature review
10.3390/cancers16081483 · 2024 · External reference
Survival according to the site of metastasis in triple-negative breast cancer patients: the Peruvian experience
10.1371/journal.pone.0293833 · 2024 · External reference
Targeting triple negative breast cancer stem cells using nanocarriers
10.1186/s11671-024-03985-y · 2024 · External reference
Co-expression of HIF1A with multi-drug transporters (P-GP, MRP1, and BCRP) in chemoresistant breast, colorectal, and ovarian cancer cells
10.1016/j.jgeb.2025.100496 · 2025 · External reference
Inhibition of CRM1 reverses hypoxia-driven chemoresistance in acute myeloid leukemia via overcoming HIF-1α-mediated lysosomal sequestration
10.3389/fimmu.2025.1710230 · 2025 · External reference
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
10.3389/fonc.2023.1199105 · 2023 · External reference
Minibeam radiation therapy remodels tumor microenvironment and suppresses HIF-1α/VEGFR axis to overcome radioresistance in triple-negative breast cancer
10.1038/s41698-025-01178-z · 2025 · External reference
Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors
2025 · External reference
Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication
2025 · External reference
The histological structure of some human lung cancers and the possible implications for radiotherapy
10.1038/bjc.1955.55 · 1955 · External reference
Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma
10.1186/s12951-024-02717-9 · 2024 · External reference
Liposome-encapsulated hemoglobin ameliorates tumor hypoxia and enhances radiation therapy to suppress tumor growth in mice
10.1111/j.1525-1594.2011.01418.x · 2012 · External reference
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
1986 · External reference
Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting
10.1016/j.bioadv.2025.214636 · 2026 · External reference
The dose threshold for nanoparticle tumour delivery
10.1038/s41563-020-0755-z · 2020 · External reference
Hybrid liposome-erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation
10.1093/rb/rbad045 · 2023 · External reference
Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance
10.1002/smll.201502388 · 2015 · External reference
Investigating hypoxia-inducible factor signaling in cancer: mechanisms, clinical implications, targeted therapeutic strategies, and resistance
10.1016/j.cpt.2025.07.003 · 2026 · External reference
An enhanced scrutiny of mechanistic and translational approaches to extinguish cancer hypoxia
10.2174/0122117385328105241216042016 · 2024 · External reference
Polymer micelles vs polymer-lipid hybrid vesicles: a comparison using RAW 264.7 cells
10.1021/acs.biomac.1c01403 · 2022 · External reference
Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype
10.1158/1078-0432.ccr-11-0397 · 2011 · External reference
Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment
10.1016/j.neo.2015.08.005 · 2015 · External reference
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
10.1038/nrc2397 · 2008 · External reference
Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing
10.1186/s12951-022-01349-1 · 2022 · External reference
